Osama Omrani, Nema Hafezi-Bakhtiari, Peter DeSouza, Christos Nikola, Ken Wong, Joseph Lansley, Permesh Dhillon, Levansri Makalanda, Nathan Chan, Thomas Harrison, Alex Andrews, Isabel Siow, Keng Siang Lee, Leonard Yeo, Oliver Spooner, Pervinder Bhogal
{"title":"Embotrap III 支架截留器在实际应用中的初步经验。","authors":"Osama Omrani, Nema Hafezi-Bakhtiari, Peter DeSouza, Christos Nikola, Ken Wong, Joseph Lansley, Permesh Dhillon, Levansri Makalanda, Nathan Chan, Thomas Harrison, Alex Andrews, Isabel Siow, Keng Siang Lee, Leonard Yeo, Oliver Spooner, Pervinder Bhogal","doi":"10.1177/15910199221142097","DOIUrl":null,"url":null,"abstract":"<p><strong>Materials and methods: </strong>We performed a retrospective review of our prospectively maintained database to identify all patients treated with the Embotrap 3 stent-retriever between January 2021 and January 2022. We recorded the baseline demographics, NIHSS, ASPECT score and clot characteristics, first pass and final eTICI scores, complications and 90 day mRS.</p><p><strong>Results: </strong>One hundred and ten patients met the inclusion criteria, average age 69 ± 14 years, 50% were male (<i>n</i> = 55). The median NIHSS at presentation was 18 (range 3-30) and 58.2% received IV tPA prior to MT. The median ASPECT score on plain CT was 8 with average clot length 20.2 ± 14.8 mm (<i>n</i> = 93). The first pass effect (FPE) was seen in 41.8% of cases with modified FPE seen in 59.1%. A 24-hour CT scan (<i>n</i> = 97) showed median ASPECTs of 7. 43.8% of patients achieve mRS ≤ 2 at 90-day mRS (<i>n</i> = 64).</p><p><strong>Conclusion: </strong>The Embotrap 3 stent-retriever has a high rate of FPE and final recanalization in this real world cohort of patients.</p>","PeriodicalId":14380,"journal":{"name":"Interventional Neuroradiology","volume":" ","pages":"663-671"},"PeriodicalIF":1.7000,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11569467/pdf/","citationCount":"0","resultStr":"{\"title\":\"The initial experience with the Embotrap III stent-retriever in a real world setting.\",\"authors\":\"Osama Omrani, Nema Hafezi-Bakhtiari, Peter DeSouza, Christos Nikola, Ken Wong, Joseph Lansley, Permesh Dhillon, Levansri Makalanda, Nathan Chan, Thomas Harrison, Alex Andrews, Isabel Siow, Keng Siang Lee, Leonard Yeo, Oliver Spooner, Pervinder Bhogal\",\"doi\":\"10.1177/15910199221142097\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Materials and methods: </strong>We performed a retrospective review of our prospectively maintained database to identify all patients treated with the Embotrap 3 stent-retriever between January 2021 and January 2022. We recorded the baseline demographics, NIHSS, ASPECT score and clot characteristics, first pass and final eTICI scores, complications and 90 day mRS.</p><p><strong>Results: </strong>One hundred and ten patients met the inclusion criteria, average age 69 ± 14 years, 50% were male (<i>n</i> = 55). The median NIHSS at presentation was 18 (range 3-30) and 58.2% received IV tPA prior to MT. The median ASPECT score on plain CT was 8 with average clot length 20.2 ± 14.8 mm (<i>n</i> = 93). The first pass effect (FPE) was seen in 41.8% of cases with modified FPE seen in 59.1%. A 24-hour CT scan (<i>n</i> = 97) showed median ASPECTs of 7. 43.8% of patients achieve mRS ≤ 2 at 90-day mRS (<i>n</i> = 64).</p><p><strong>Conclusion: </strong>The Embotrap 3 stent-retriever has a high rate of FPE and final recanalization in this real world cohort of patients.</p>\",\"PeriodicalId\":14380,\"journal\":{\"name\":\"Interventional Neuroradiology\",\"volume\":\" \",\"pages\":\"663-671\"},\"PeriodicalIF\":1.7000,\"publicationDate\":\"2024-10-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11569467/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Interventional Neuroradiology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1177/15910199221142097\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2022/12/15 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q3\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Interventional Neuroradiology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1177/15910199221142097","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2022/12/15 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
The initial experience with the Embotrap III stent-retriever in a real world setting.
Materials and methods: We performed a retrospective review of our prospectively maintained database to identify all patients treated with the Embotrap 3 stent-retriever between January 2021 and January 2022. We recorded the baseline demographics, NIHSS, ASPECT score and clot characteristics, first pass and final eTICI scores, complications and 90 day mRS.
Results: One hundred and ten patients met the inclusion criteria, average age 69 ± 14 years, 50% were male (n = 55). The median NIHSS at presentation was 18 (range 3-30) and 58.2% received IV tPA prior to MT. The median ASPECT score on plain CT was 8 with average clot length 20.2 ± 14.8 mm (n = 93). The first pass effect (FPE) was seen in 41.8% of cases with modified FPE seen in 59.1%. A 24-hour CT scan (n = 97) showed median ASPECTs of 7. 43.8% of patients achieve mRS ≤ 2 at 90-day mRS (n = 64).
Conclusion: The Embotrap 3 stent-retriever has a high rate of FPE and final recanalization in this real world cohort of patients.
期刊介绍：
Interventional Neuroradiology (INR) is a peer-reviewed clinical practice journal documenting the current state of interventional neuroradiology worldwide. INR publishes original clinical observations, descriptions of new techniques or procedures, case reports, and articles on the ethical and social aspects of related health care. Original research published in INR is related to the practice of interventional neuroradiology...
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
